In vivo pharmacokinetics and pharmacodynamics in drug development using positron-emission tomography
- 12 March 2001
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (6), 293-302
- https://doi.org/10.1016/s1359-6446(01)01684-1
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug actionThe Lancet, 2000
- Radio-imaging in small animals.Journal of Psychopharmacology, 1999
- The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitroNuclear Medicine and Biology, 1998
- Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.The International Journal of Cardiovascular Imaging, 1997
- From triazines and triazenes to temozolomideEuropean Journal Of Cancer, 1993
- Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomographyAntimicrobial Agents and Chemotherapy, 1993
- The Discovery and Profile of FluconazoleJournal of Chemotherapy, 1990
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamideJournal of Medicinal Chemistry, 1987
- Local Cerebral Metabolic Changes in Acute Ischemic StrokesGerontology, 1987